167 related articles for article (PubMed ID: 22200011)
1. Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.
Kim JY; Kim ST; Nam DH; Lee JI; Park K; Kong DS
J Korean Neurosurg Soc; 2011 Oct; 50(4):304-10. PubMed ID: 22200011
[TBL] [Abstract][Full Text] [Related]
2. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
[TBL] [Abstract][Full Text] [Related]
3. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
[TBL] [Abstract][Full Text] [Related]
4. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.
Boogerd W; vd Sande JJ; Moffie D
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1277-83. PubMed ID: 3225584
[TBL] [Abstract][Full Text] [Related]
5. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
6. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.
Rubinstein LJ; Herman MM; Long TF; Wilbur JR
Cancer; 1975 Feb; 35(2):291-305. PubMed ID: 1053934
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
8. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Raghavendra S; Nair MD; Chemmanam T; Krishnamoorthy T; Radhakrishnan VV; Kuruvilla A
Eur J Neurol; 2007 Mar; 14(3):309-14. PubMed ID: 17355553
[TBL] [Abstract][Full Text] [Related]
9. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia.
Thompson CB; Sanders JE; Flournoy N; Buckner CD; Thomas ED
Blood; 1986 Jan; 67(1):195-9. PubMed ID: 3510066
[TBL] [Abstract][Full Text] [Related]
10. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
Matsumoto K; Takahashi S; Sato A; Imaizumi M; Higano S; Sakamoto K; Asakawa H; Tada K
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):913-8. PubMed ID: 7607965
[TBL] [Abstract][Full Text] [Related]
11. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
[TBL] [Abstract][Full Text] [Related]
12. Continuous intrathecal injection therapy of methotrexate is a therapeutic option in primary CNS lymphoma.
Otani R; Yamada R; Kushihara Y; Inazuka M; Shinoura N
J Clin Neurosci; 2019 Nov; 69():26-30. PubMed ID: 31466902
[TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.
Matsubayashi J; Tsuchiya K; Matsunaga T; Mukai K
Neuropathology; 2009 Apr; 29(2):105-15. PubMed ID: 18627488
[TBL] [Abstract][Full Text] [Related]
15. Leukoencephalopathy following combined therapy of central nervous system leukemia and lymphoma.
Rubinstein JL; Herman MM; Long TF; Wilbur JR
Acta Neuropathol Suppl; 1975; Suppl 6():251-5. PubMed ID: 1057358
[TBL] [Abstract][Full Text] [Related]
16. [Case of disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in acute lymphocytic leukemia].
Nakashima A; Morimatsu M; Mukae T; Nagayama K; Nakashima T; Hino Y
Gan No Rinsho; 1983 Feb; 29(2):A-9, 138-42. PubMed ID: 6576180
[TBL] [Abstract][Full Text] [Related]
17. MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.
Oka M; Terae S; Kobayashi R; Sawamura Y; Kudoh K; Tha KK; Yoshida M; Kaneda M; Suzuki Y; Miyasaka K
Neuroradiology; 2003 Jul; 45(7):493-7. PubMed ID: 12761601
[TBL] [Abstract][Full Text] [Related]
18. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy.
Suzuki K; Takemura T; Okeda R; Hatakeyama S
Acta Neuropathol; 1984; 65(2):145-9. PubMed ID: 6596829
[TBL] [Abstract][Full Text] [Related]
19. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients.
Schroyen G; Meylaers M; Deprez S; Blommaert J; Smeets A; Jacobs S; Sunaert S; Sleurs C; Uyttebroeck A
J Chemother; 2020 Nov; 32(7):327-343. PubMed ID: 32799637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
